{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:37:48Z","timestamp":1790469468115,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.omtm.2019.01.005","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T06:43:20Z","timestamp":1548571400000},"page":"187-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["High-Efficiency Lentiviral Transduction of Human CD34+ Cells in High-Density Culture with Poloxamer and Prostaglandin E2"],"prefix":"10.1016","volume":"13","author":[{"given":"Naoya","family":"Uchida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Nassehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Drysdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Gamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Yapundich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selami","family":"Demirci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Haro-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Tisdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.01.005_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2019.01.005_bib2","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.omtm.2019.01.005_bib3","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-cell gene therapy for the Wiskott-Aldrich syndrome","volume":"363","author":"Boztug","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2019.01.005_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.omtm.2019.01.005_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2019.01.005_bib6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2019.01.005_bib7","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMoa1609677","article-title":"Gene Therapy in a Patient with Sickle Cell Disease","volume":"376","author":"Ribeil","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2019.01.005_bib8","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1182\/blood.V128.22.1176.1176","article-title":"Interim Results from a Phase 1\/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease","volume":"128","author":"Kanter","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2019.01.005_bib9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/gt.2011.63","article-title":"Optimal conditions for lentiviral transduction of engrafting human CD34+ cells","volume":"18","author":"Uchida","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2019.01.005_bib10","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/mt.2012.159","article-title":"High-efficiency transduction of rhesus hematopoietic repopulating cells by a modified HIV1-based lentiviral vector","volume":"20","author":"Uchida","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.01.005_bib11","doi-asserted-by":"crossref","first-page":"9854","DOI":"10.1128\/JVI.00357-09","article-title":"Development of a human immunodeficiency virus type 1-based lentiviral vector that allows efficient transduction of both human and rhesus blood cells","volume":"83","author":"Uchida","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.01.005_bib12","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1073\/pnas.1214441110","article-title":"LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus","volume":"110","author":"Finkelshtein","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.01.005_bib13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.stem.2011.02.003","article-title":"Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models","volume":"8","author":"Goessling","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2019.01.005_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.exphem.2015.10.003","article-title":"Kinetics of lentiviral vector transduction in human CD34(+) cells","volume":"44","author":"Uchida","year":"2016","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.omtm.2019.01.005_bib15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/JVI.01089-06","article-title":"Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in\u00a0vitro and in\u00a0vivo","volume":"81","author":"Pan","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.01.005_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0166-0934(89)90132-8","article-title":"Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy","volume":"23","author":"Cornetta","year":"1989","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.omtm.2019.01.005_bib17","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/am.22.6.1162-1163.1971","article-title":"Effect of polycations on sensitivity of BALD-3T3 cells to murine leukemia and sarcoma virus infectivity","volume":"22","author":"Manning","year":"1971","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.omtm.2019.01.005_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0169-409X(02)00018-2","article-title":"Pluronic block copolymers: novel functional molecules for gene therapy","volume":"54","author":"Kabanov","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtm.2019.01.005_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/jgm.2653","article-title":"Poloxamer synperonic F108 improves cellular transduction with lentiviral vectors","volume":"14","author":"H\u00f6fig","year":"2012","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtm.2019.01.005_bib20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ymthe.2017.09.025","article-title":"Prostaglandin E2 Increases Lentiviral Vector Transduction Efficiency of Adult Human Hematopoietic Stem and Progenitor Cells","volume":"26","author":"Heffner","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.01.005_bib21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/mthe.2002.0549","article-title":"Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood","volume":"5","author":"Hanawa","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.01.005_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1272\/jnms.76.134","article-title":"Leukemogenesis of b2a2-type p210 BCR\/ABL in a bone marrow transplantation mouse model using a lentiviral vector","volume":"76","author":"Uchida","year":"2009","journal-title":"J.\u00a0Nippon Med. Sch."},{"key":"10.1016\/j.omtm.2019.01.005_bib23","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1038\/mtna.2013.49","article-title":"Integration-specific In\u00a0Vitro Evaluation of Lentivirally Transduced Rhesus CD34(+) Cells Correlates With In\u00a0Vivo Vector Copy Number","volume":"2","author":"Uchida","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2019.01.005_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/mt.2010.218","article-title":"Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector","volume":"19","author":"Uchida","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.01.005_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.omtm.2018.03.007","article-title":"Serum-free Erythroid Differentiation for Efficient Genetic Modification and High-Level Adult Hemoglobin Production","volume":"9","author":"Uchida","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2019.01.005_bib26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/stem.2517","article-title":"Efficient Generation of \u03b2-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells from Patients with Sickle Cell Disease","volume":"35","author":"Uchida","year":"2017","journal-title":"Stem Cells"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119300087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119300087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:25:13Z","timestamp":1762421113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050119300087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":26,"alternative-id":["S2329050119300087"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.01.005","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Efficiency Lentiviral Transduction of Human CD34+ Cells in High-Density Culture with Poloxamer and Prostaglandin E2","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}